Advertisement

Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus–related liver carcinogenesis

Published:September 05, 2015DOI:https://doi.org/10.1016/j.trsl.2015.08.012
      In viral hepatitis, inflammation is correlated with chronic oxidative stress, one of the biological events leading to DNA damage and hepatocellular carcinoma (HCC) development. Aim of this study was to investigate the complex molecular network linking oxidative damage to telomere length and telomerase activity and regulation in hepatitis C and B virus–related liver carcinogenesis. We investigated 142 patients: 21 with HCC (in both tumor and peritumor tissues) and 121 with chronic viral hepatitis in different stages. We evaluated 8-hydroxydeoxyguanosine (8-OHdG), marker of oxidative DNA damage, OGG1 gene polymorphism, telomere length, telomerase activity, TERT promoter methylation, and mitochondrial TERT localization. In hepatitis C–related damage, 8-OHdG levels increased since the early disease stages, whereas hepatitis B–related liver disease was characterized by a later and sharper 8-OHdG accumulation (P = 0.005). In C virus–infected patients, telomeres were shorter (P = 0.03), whereas telomerase activity was higher in tumors than that in the less advanced stages of disease in both groups (P = 0.0001, P = 0.05), with an earlier increase in hepatitis C. Similarly, TERT promoter methylation was higher in tumor and peritumor tissues in both groups (P = 0.02, P = 0.0001). Finally, TERT was localized in mitochondria in tumor and peritumor samples, with 8-OHdG levels significantly lower in mitochondrial than those in genomic DNA (P = 0.0003). These data describe a pathway in which oxidative DNA damage accumulates in correspondence with telomere shortening, telomerase activation, and TERT promoter methylation with a different time course in hepatitis B and C virus–related liver carcinogenesis. Finally, TERT localizes in mitochondria in HCC, where it lacks a canonical function.

      Abbreviations:

      HCC (hepatocellular carcinoma), HCV (hepatitis C virus), HBV (hepatitis B virus), ROS (reactive oxygen species), 8-OHdG (8-hydroxydeoxyguanosine), TU-HCC (tumor-hepatocellular carcinoma), PTU-HCC (peritumor-hepatocellular carcinoma), F0-F4 (fibrosis stages), nDNA (nuclear DNA), mtDNA (mitochondrial DNA), dG (deoxyguanosine), GAPDH (glyceraldehyde 3-phosphate dehydrogenase), C (control), ELISA (enzyme-linked immunosorbent assay), AP (apurinic), RIBA II (recombinant immunoblot assay), PCR (polymerase chain reaction), HBsAg (hepatitis B surface antigen), HBe (hepatitis B e-antigen), EASL (European Association for the Study of the Liver), SDS-PAGE (sodium dodecyl sulphate-polyacrylamide gel electrophoresis), PBS (phosphate buffered saline), AASLD (American Association for the Study of Liver Diseases), HPLC (high performance liquid chromatography), UV (ultraviolet), RFLP (restriction fragment length polymorphism), BSA (bovine serum albumin), SEM (standard error of the mean), ANOVA (analysis of variance)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Allavena P.
        • Mantovani A.
        Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.
        Clin Exp Immunol. 2012; 167: 195-205
        • Mantovani A.
        Molecular pathways linking inflammation and cancer.
        Curr Mol Med. 2010; 10: 369-373
        • Aravalli R.N.
        • Cressman E.N.
        • Steer C.J.
        Cellular and molecular mechanisms of hepatocellular carcinoma: an update.
        Arch Toxicol. 2013; 87: 227-247
        • Fujita N.
        • Sugimoto R.
        • Ma N.
        • et al.
        Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
        J Viral Hepat. 2008; 15: 498-507
        • Klaunig J.E.
        • Kamendulis L.M.
        • Hocevar B.A.
        Oxidative stress and oxidative damage in carcinogenesis.
        Toxicol Pathol. 2010; 38: 96-109
        • Kohno T.
        • Shinmura K.
        • Tosaka M.
        • et al.
        Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA.
        Oncogene. 1998; 16: 3219-3225
        • Oikawa S.
        • Kawanishi S.
        Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening.
        FEBS Lett. 1999; 453: 365-368
        • Iliopoulos D.
        • Satra M.
        • Drakaki A.
        • Poultsides G.A.
        • Tsezou A.
        Epigenetic regulation of hTERT promoter in hepatocellular carcinomas.
        Int J Oncol. 2009; 34: 391-399
        • Maser R.S.
        • DePinho R.A.
        Connecting chromosomes, crisis, and cancer.
        Science. 2002; 297: 565-569
        • Edmondson H.A.
        • Steiner P.E.
        Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.
        Cancer. 1954; 7: 462-503
        • Bruix J.
        • Sherman M.
        • Llovet J.M.
        • et al.
        Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.
        J Hepatol. 2001; 35: 421-430
        • Omata M.
        • Lesmana L.A.
        • Tateishi R.
        • et al.
        Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.
        Hepatol Int. 2010; 4: 439-474
        • Knodell R.G.
        • Ishak K.G.
        • Black W.C.
        • et al.
        Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.
        Hepatology. 1981; 1: 431-435
        • Brunt E.M.
        • Janney C.G.
        • Di Bisceglie A.M.
        • Neuschwander-Tetri B.A.
        • Bacon B.R.
        Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
        Am J Gastroenterol. 1999; 94: 2467-2474
        • Cardin R.
        • Piciocchi M.
        • Sinigallia A.
        • et al.
        Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma.
        BMC Cancer. 2012; 12 (in Pubmed the Authors' names are mistakenly reported as Romilda C, Marika P, Alessandro S, Enrico L, Marina B, Andromachi K, et al.): 177
        • Cawthon R.M.
        Telomere measurement by quantitative PCR.
        Nucleic Acids Res. 2002; 30: e47
        • Guilleret I.
        • Benhattar J.
        Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.
        Biochem Biophys Res Commun. 2004; 325: 1037-1043
        • Dimauro I.
        • Pearson T.
        • Caporossi D.
        • Jackson M.J.
        A simple protocol for the subcellular fractionation of skeletal muscle cells and tissue.
        BMC Res Notes. 2012; 5: 513
        • Cardin R.
        • Saccoccio G.
        • Masutti F.
        • Bellentani S.
        • Farinati F.
        • Tiribelli C.
        DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study.
        J Hepatol. 2001; 34: 587-592
        • Raimondi S.
        • Bruno S.
        • Mondelli M.U.
        • Maisonneuve P.
        Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis.
        J Hepatol. 2009; 50: 1142-1154
        • Shan Y.S.
        • Hsieh Y.H.
        • Lin P.W.
        Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection.
        World J Surg. 2007; 31: 1121-1128
        • Moriya K.
        • Nakagawa K.
        • Santa T.
        • et al.
        Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis.
        Cancer Res. 2001; 61: 4365-4370
        • Toh S.T.
        • Jin Y.
        • Liu L.
        • et al.
        Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
        Carcinogenesis. 2013; 34: 787-798
        • Ding D.
        • Lou X.
        • Hua D.
        • et al.
        Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach.
        PLoS Genet. 2012; 8: e1003065
        • Paterlini-Bréchot P.
        • Saigo K.
        • Murakami Y.
        • et al.
        Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.
        Oncogene. 2003; 22: 3911-3916
        • Guerrieri F.
        • Belloni L.
        • Pediconi N.
        • Levrero M.
        Molecular mechanisms of HBV-associated hepatocarcinogenesis.
        Semin Liver Dis. 2013; 33: 147-156
        • Arzumanyan A.
        • Reis H.M.
        • Feitelson M.A.
        Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.
        Nat Rev Cancer. 2013; 13: 123-135
        • Bouchard M.J.
        • Navas-Martin S.
        Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.
        Cancer Lett. 2011; 305: 123-143
        • Gearhart T.L.
        • Bouchard M.J.
        The hepatitis B virus HBx protein modulates cell cycle regulatory proteins in cultured primary human hepatocytes.
        Virus Res. 2011; 155: 363-367
        • El Idrissi M.
        • Hervieu V.
        • Merle P.
        • Mortreux F.
        • Wattel E.
        Cause-specific telomere factors deregulation in hepatocellular carcinoma.
        J Exp Clin Cancer Res. 2013; 32: 64
        • Sekoguchi S.
        • Nakajima T.
        • Moriguchi M.
        • et al.
        Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C.
        J Gastroenterol Hepatol. 2007; 22: 182-190
        • Houben J.M.
        • Moonen H.J.
        • van Schooten F.J.
        • Hageman G.J.
        Telomere length assessment: biomarker of chronic oxidative stress?.
        Free Radic Biol Med. 2008; 44: 235-246
        • Oh B.K.
        • Kim H.
        • Park Y.N.
        • et al.
        High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
        Lab Invest. 2008; 88: 144-152
        • Saini N.
        • Srinivasan R.
        • Chawla Y.
        • Sharma S.
        • Chakraborti A.
        • Rajwanshi A.
        Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
        Liver Int. 2009; 29: 1162-1170
        • Miura N.
        • Horikawa I.
        • Nishimoto A.
        • et al.
        Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
        Cancer Genet Cytogenet. 1997; 93: 56-62
        • Lambert M.P.
        • Paliwal A.
        • Vaissière T.
        • et al.
        Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.
        J Hepatol. 2011; 54: 705-715
        • Ozen C.
        • Yildiz G.
        • Dagcan A.T.
        • et al.
        Genetics and epigenetics of liver cancer.
        N Biotechnol. 2013; 30: 381-384
        • Zhu J.
        • Zhao Y.
        • Wang S.
        Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene.
        Protein Cell. 2010; 1: 22-32
        • Jakob S.
        • Schroeder P.
        • Lukosz M.
        • et al.
        Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase.
        J Biol Chem. 2008; 283: 33155-33161
        • Buchner N.
        • Zschauer T.-C.
        • Lukosz M.
        • Altschmied J.
        • Haendeler J.
        Downregulation of mitochondrial telomerase reverse transcriptase induced by H2O2 is Src kinase dependent.
        Exp Gerontol. 2010; 45: 558-562
        • Santos J.H.
        • Meyer J.N.
        • Van Houten B.
        Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis.
        Hum Mol Genet. 2006; 15: 1757-1768
        • Indran I.R.
        • Hande M.P.
        • Pervaiz S.
        hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells.
        Cancer Res. 2011; 71: 266-276
        • Haendeler J.
        • Dröse S.
        • Büchner N.
        • et al.
        Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage.
        Arterioscler Thromb Vasc Biol. 2009; 29: 929-935
        • Nomoto K.
        • Tsuneyama K.
        • Takahashi H.
        • Murai Y.
        • Takano Y.
        Cytoplasmic fine granular expression of 8-hydroxydeoxyguanosine reflects early mitochondrial oxidative DNA damage in Nonalcoholic fatty liver disease.
        Appl Immunohistochem Mol Morphol. 2008; 16: 71-75
        • Ralph S.J.
        • Rodríguez-Enríquez S.
        • Neuzil J.
        • Saavedra E.
        • Moreno-Sánchez R.
        The causes of cancer revisited: “mitochondrial malignancy” and ROS-induced oncogenic transformation—why mitochondria are targets for cancer therapy.
        Mol Aspects Med. 2010; 31: 145-170
        • Tauskela J.S.
        MitoQ–a mitochondria-targeted antioxidant.
        Drugs. 2007; 10: 399-412